B‐cell haematological malignancies and SARS‐CoV‐2 infection: Could immunological interventions influence the outcome?

Autor: Juliana Ochoa‐Grullón, Ascensión Peña Cortijo, Kissy Guevara‐Hoyer, Carlos Jiménez García, Eduardo de laFuente, Antonia Rodríguez de laPeña, Miguel Fernández‐Arquero, Ata González Fernández, Silvia Sánchez‐Ramón

Publikováno v: eJHaem, Vol 2, Iss 3, Pp 503-507 (2021)

Abstract B cell haematological malignancies (HMs) have been described as the worst cancer type for concomitant COVID‐19 in terms of mortality, with rates up to 65%. This risk factor for COVID‐19 cannot only be explained by comorbidities and advan

Externí odkaz: https://doaj.org/article/ccaec037aacf4f7f8ac65670ed2b1924

Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression

Autor: Juliana Ochoa-Grullón, Kissy Guevara-Hoyer, Cristina Pérez López, Rebeca Pérez de Diego, Ascensión Peña Cortijo, Marta Polo, Marta Mateo Morales, Eduardo Anguita Mandley, Carlos Jiménez García, Estefanía Bolaños, Belén Íñigo, Fiorella Medina, Antonia Rodríguez de la Peña, Carmen Izquierdo Delgado, Eduardo de la Fuente Muñoz, Elsa Mayol, Miguel Fernández-Arquero, Ataúlfo González-Fernández, Celina Benavente Cuesta, Silvia Sánchez-Ramón

Publikováno v: Biomedicines, Vol 10, Iss 8, p 2020 (2022)

B cell chronic lymphoproliferative diseases (B-CLPD) are associated with secondary antibody deficiency and other innate and adaptive immune defects, whose impact on infectious risk has not been systematically addressed. We performed an immunological

Externí odkaz: https://doaj.org/article/2c58009c0a8949bdb97d780d45554d89

Therapy-related myeloid neoplasms as a concerning complication in acute promyelocytic leukemia

Autor: María del Carmen Vicente-Ayuso, María García-Roa, Ataúlfo González-Fernández, Ana María Alvarez-Carmona, Celina Benavente-Cuesta, Marta Mateo-Morales, Cristina Pérez-López, Ascensión Peña-Cortijo, Marta Polo Zarzuela, Laura Gutiérrez, Rafael Martínez-Martínez

Publikováno v: Hematology Reports, Vol 9, Iss 3 (2017)

Acute promyelocytic leukemia (APL) has become a highly curable malignant disease after the introduction of all transretinoic acid (ATRA) to chemotherapy treatment. However, the risk to develop therapy-related myeloid neoplasms (t-MN) has become a mat

Externí odkaz: https://doaj.org/article/6397ea9f4b5241ac809afc9c68f014f0

Specific Cellular and Humoral Immune Responses to the Neoantigen S1 of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency

Autor: Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García, Laura García Bravo, Adolfo Jiménez Huete, Antonia Rodríguez de la Peña, Beatriz Mediero Valeros, Cristina Cañizares Velázquez, Esther Culebras López, Noemi Cabello, Vicente Estrada, Ángel López Corbi, Miguel Fernández Arquero, Alberto Ocaña, Alberto Delgado-Iribarren, Mercedes Martínez Novillo, Estefania Bolaños, Eduardo Anguita, Ascensión Peña, Celina Benavente, Javier David Benítez Fuentes, Pedro Perez Segura, Silvia Sanchez-Ramon

Patients with antibody deficiency disorders, such as common variable immunodeficiency (CVID), or secondary immunodeficiency (SIDs) to B-cell lymphoproliferative disorder (B-CLPD), are two vulnerable groups of developing severe or chronic form of coro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d40e37775ce6feb0ee19a6a2d359851e
https://doi.org/10.21203/rs.3.rs-1645228/v1

Therapy-related myeloid neoplasms as a concerning complication in acute promyelocytic leukemia

Autor: Marta Mateo-Morales, Rafael Martínez-Martínez, Celina Benavente-Cuesta, Ana María Alvarez-Carmona, Laura Gutierrez, María del Carmen Vicente-Ayuso, Marta Polo Zarzuela, Ascensión Peña-Cortijo, Cristina Pérez-López, Ataúlfo González-Fernández, María García-Roa

Publikováno v: Hematology Reports
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Hematology Reports, Vol 9, Iss 3 (2017)

Acute promyelocytic leukemia (APL) has become a highly curable malignant disease after the introduction of all transretinoic acid (ATRA) to chemotherapy treatment. However, the risk to develop therapy-related myeloid neoplasms (t-MN) has become a mat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e037cb2cf161372989b6d3d22a5f40
http://europepmc.org/articles/PMC5641840